AQP4 and neoplasm: While tumor screening may in fact be indicated in individual patients, depending on the presence of risk factors or symptoms suggestive of an underlying or co-existing tumor, general screening of all patients with newly diagnosed AQP4-IgG-positive NMOSD for cancer—especially by means of invasive or otherwise potentially harmful methods—is currently not recommended.